Target intelligence / Profile preview

T cell receptor alpha joining 56 (TRAJ56)

Target
TRAJ56
Molecular classification
Other (Immunoglobulin/T cell receptor gene segment)
01

Overview

T cell receptor alpha joining 56 (TRAJ56) is one of the joining (J) gene segments within the T cell receptor alpha locus in humans[2][3][4][7]. The TRAJ56 gene segment does not encode a standalone functional protein or receptor but instead serves as a genetic building block that contributes to forming the variable region of the T cell receptor alpha (TRA) chain through somatic recombination during T cell development[5][8]. The full T cell receptor is a heterodimeric complex (usually alpha and beta chains), crucial for T cell recognition of antigens presented by the major histocompatibility complex (MHC)[5][7][8]. TRAJ56 itself is not considered a receptor, enzyme, transporter, or direct therapeutic target but is part of the genetic mechanism creating T cell diversity. Clarification: TRAJ56 is a gene segment, not a full protein/receptor, and does not function independently as a therapeutic target. It cannot be directly targeted by drugs, nor does it serve as a biomarker or have a direct role in disease or drug mechanism. Its relevance is strictly genomic, as a component part of T cell receptor diversity[7][8].

Other names
T cell receptor alpha joining 56TRAJ56
02

Biological functions

Immune response

Beyond the preview

Go deeper on T cell receptor alpha joining 56 (TRAJ56).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on T cell receptor alpha joining 56 (TRAJ56).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call